A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Surgery

NCT01897519 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
56
Enrollment
INDUSTRY
Sponsor class

Stopped Topline results from study M13-796 showed an overall lack of efficacy. There were no safety concerns.

Conditions

Interventions

Sponsor

AbbVie